Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Amdocs (DOX) over the last 17 years, with Q3 2025 value amounting to $26.7 million.

  • Amdocs' Share-based Compensation rose 279.58% to $26.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $104.9 million, marking a year-over-year increase of 30.99%. This contributed to the annual value of $104.9 million for FY2025, which is 30.99% up from last year.
  • Amdocs' Share-based Compensation amounted to $26.7 million in Q3 2025, which was up 279.58% from $26.0 million recorded in Q2 2025.
  • Amdocs' Share-based Compensation's 5-year high stood at $26.7 million during Q3 2025, with a 5-year trough of $13.4 million in Q1 2021.
  • For the 5-year period, Amdocs' Share-based Compensation averaged around $21.7 million, with its median value being $24.1 million (2023).
  • As far as peak fluctuations go, Amdocs' Share-based Compensation skyrocketed by 4503.24% in 2021, and later tumbled by 262.67% in 2025.
  • Over the past 5 years, Amdocs' Share-based Compensation (Quarter) stood at $16.7 million in 2021, then increased by 16.42% to $19.5 million in 2022, then skyrocketed by 33.81% to $26.1 million in 2023, then grew by 1.69% to $26.5 million in 2024, then increased by 0.79% to $26.7 million in 2025.
  • Its Share-based Compensation was $26.7 million in Q3 2025, compared to $26.0 million in Q2 2025 and $25.7 million in Q1 2025.